OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Manish Kumar Singh, Yoonhwa Shin, Songhyun Ju, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6901-6901
Open Access | Times Cited: 5
Manish Kumar Singh, Yoonhwa Shin, Songhyun Ju, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6901-6901
Open Access | Times Cited: 5
Showing 5 citing articles:
Ameliorative role of Phosphodiesterase-5 (PDE-5) inhibitor “Avanafil” via modulating cAMP & cGMP Pathway against Alzheimer’s disease
Mohd Talib, Nazia Siddiqui, Prabhash Nath Tripathi, et al.
Research Square (Research Square) (2025)
Open Access
Mohd Talib, Nazia Siddiqui, Prabhash Nath Tripathi, et al.
Research Square (Research Square) (2025)
Open Access
Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access
Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease
Yunxiao Ren, Andrew A. Pieper, Feixiong Cheng
Neurotherapeutics (2025), pp. e00553-e00553
Open Access
Yunxiao Ren, Andrew A. Pieper, Feixiong Cheng
Neurotherapeutics (2025), pp. e00553-e00553
Open Access
Molecular Mechanisms of Dietary Bioactive Peptides in Treating Alzheimer’s Disease and Mild Cognitive Impairment by Network Pharmacology and Molecular Docking Analysis
Ruirui Li, Jing Zi, Y. Hu, et al.
Rejuvenation Research (2025)
Closed Access
Ruirui Li, Jing Zi, Y. Hu, et al.
Rejuvenation Research (2025)
Closed Access
In silico Drug Discovery of Two Novel Kojic Acid Metal Complex against CALM Protein for the Treatment of Alzheimer’s Disease
Suman Basak, Kunal Bhattacharya, Piyali Das
Journal of Preventive Diagnostic and Treatment Strategies in Medicine (2025) Vol. 4, Iss. 1, pp. 26-35
Closed Access
Suman Basak, Kunal Bhattacharya, Piyali Das
Journal of Preventive Diagnostic and Treatment Strategies in Medicine (2025) Vol. 4, Iss. 1, pp. 26-35
Closed Access
A Survey on Computational Methods in Drug Discovery for Neurodegenerative Diseases
Caterina Vicidomini, Francesco Fontanella, Tiziana D’Alessandro, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1330-1330
Open Access | Times Cited: 4
Caterina Vicidomini, Francesco Fontanella, Tiziana D’Alessandro, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1330-1330
Open Access | Times Cited: 4
Positive Effect of YB-1 and Mesenchymal Stromal Cells on Primary Hippocampal Culture under Conditions of ACE2 Receptor Blockade
D. Yu. Zhdanova, A. V. Chaplygina, N. V. Bobkova, et al.
Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology (2024) Vol. 18, Iss. S1, pp. S20-S32
Closed Access
D. Yu. Zhdanova, A. V. Chaplygina, N. V. Bobkova, et al.
Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology (2024) Vol. 18, Iss. S1, pp. S20-S32
Closed Access
